Women's Health Initiative

What Women's Health Initiative does

The Women's Health Initiative (WHI) is a federally funded longitudinal research study established in 1992 to investigate risk factors, prevention strategies, and early detection of serious health conditions in postmenopausal women. Since inception, the study has enrolled over 161,000 participants across the United States and produced 2,582 peer-reviewed publications that have shaped clinical practice, including the landmark 2002 hormone therapy findings that reshaped menopause treatment globally. The program operates through a network of six regional clinical centers hosted at major U.S. academic medical institutions (University at Buffalo, Brigham and Women's Hospital, Wake Forest School of Medicine, Ohio State University Wexner Medical Center, and Stanford) and a Clinical Coordinating Center at Fred Hutchinson Cancer Center in Seattle.

The program maintains a substantial research data infrastructure that includes a biospecimen repository with over 5.3 million specimen vials, multi-omics datasets (GWAS data for ~42,000 participants via dbGaP, whole genome sequencing via TOPMed, methylation arrays, metabolomics, proteomics, and RNA sequencing), and outcomes data extended via Medicare linkage. Researchers access data through a structured process involving Publications & Presentations Committee approval and a Data Use Agreement, with secure analysis of sensitive datasets (including Medicare linkage, geocoded addresses, and calendar dates) available through the Virtual Data Enclave. A web-based Query Builder tool allows prospective investigators to evaluate participant counts and biospecimen availability before submitting proposals.

WHI's funding model is entirely governmental, with the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), providing the majority of operational support. The program faced a significant funding crisis in April 2025 when NIH announced termination of regional center contracts; funding was restored on May 6, 2025, following public outcry. The study is not a commercial enterprise: there are no participant fees, and data access is provided at no cost to approved investigators (VDE access has been free since February 1, 2021). Ancillary studies such as COSMOS (~22,000 participants), WHIMS, LILAC, OPACH, and WHISPER extend the research portfolio into specific health domains including cardiovascular disease, dementia, cancer survivorship, physical activity, and sleep disorders.

Name

Women's Health Initiative

Legal name

Women's Health Initiative

Website

https://whi.org

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

11–50 employees

Short description

The Women's Health Initiative is a federally funded longitudinal research study launched in 1992 that has followed over 161,000 postmenopausal women to identify chronic disease risk factors and has produced 2,582 peer-reviewed publications shaping clinical practice in women's health.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in the Social Sciences and Humanities (541720)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro primary industry

Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM)

akta.pro secondary industries

Health Information Exchange & Public Health Data Integration (HLAJAJAD), Menopause & Midlife Women’s Health (HLAKAJAH), Economic Evaluation & Health Technology Assessment (Public Programs) (HLAJANAL)

Keywords

• Women's health research
• Longitudinal cohort study
• Clinical trials research
• Biospecimen repository services
• Postmenopausal health studies

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Others

Revenue model

1. Federal Research Funding: WHI is primarily funded by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), under the U.S. Department of Health and Human Services. Funding was threatened in April 2025 but was subsequently restored after public outcry.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

The Women's Health Initiative (WHI) is a landmark longitudinal research study operating since 1992 to investigate risk factors, prevention strategies, and early detection methods for serious health conditions in postmenopausal women. The program makes cumulative participant datasets, a 5.3 million-vial biospecimen repository, multi-omics data, and secure analysis infrastructure available to approved investigators through structured proposal and Data Use Agreement processes. It also includes multiple ancillary studies (COSMOS, WHIMS, LILAC, OPACH, WHISPER) extending research into specific health domains such as cardiovascular disease, cancer, cognitive aging, physical activity, and sleep-disordered breathing.

Product overview

The Women's Health Initiative (WHI) is a landmark research study program (since 1992) focused on postmenopausal women's health, comprising multiple integrated components: the core WHI Study with Clinical Trials (Hormone Therapy, Dietary Modification, Calcium/Vitamin D) and Observational Study; investigator datasets and data dictionaries providing research access; the Query Builder tool for data exploration; the Virtual Data Enclave for secure analysis; and a biospecimen repository. The program is supported by numerous ancillary studies including COSMOS, WHIMS, LILAC, OPACH, and WHISPER that extend the core research into specific health domains. Data and specimens are made available to approved researchers through a structured proposal and data use agreement process.

Differentiator

Problem solved

Functional benefit

Products and services

• Women's Health Initiative (WHI) Study A landmark longitudinal research study since 1992 investigating risk factors, prevention, and early detection of serious health conditions in postmenopausal women. Includes clinical trials (Hormone Therapy, Dietary Modification, Calcium/Vitamin D) and an Observational Study component. For academic researchers, epidemiologists, and clinical investigators studying women's health.
• WHI Investigator Datasets

Quantifiable outcome

• 12,600 fewer breast cancer cases annually attributed to WHI research findings
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core and major.

• Fred Hutchinson Cancer CentercoreStrategic or Co-development PartnerHosts the WHI Clinical Coordinating Center (CCC), which manages data collection, quality control, and distribution. Provides administrative infrastructure, secure data systems, and staff support for the study.
• Regional Clinical Centers (6 sites)coreStrategic or Co-development PartnerNetwork of 6 regional centers (University at Buffalo, Brigham and Women's Hospital, Wake Forest, Ohio State, Stanford, and former sites) that recruit and retain participants, collect data and biospecimens, and conduct local study activities.
• COSMOS Trial ConsortiummajorStrategic or Co-development PartnerCOcoa Supplement and Multivitamin Outcomes Study - a large ancillary study of ~22,000 participants investigating whether cocoa flavanols and multivitamins reduce risk of heart disease, stroke, and cancer. Major extension of WHI research.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Nurses' Health Study: The Nurses' Health Study (NHS and NHS II) is one of the largest and longest-running investigations of women's health, following over 275,000 female nurses since 1976. It is highly comparable to WHI as a longitudinal women's health cohort study with biospecimen collection, funded by NIH, that has produced landmark findings on chronic disease risk factors and women's health outcomes.
• Health and Retirement Study (HRS): HRS is a nationally representative longitudinal panel study of approximately 20,000 Americans over age 50, funded by NIA and SSA. Comparable to WHI as a long-running aging-focused cohort study with rich longitudinal data, biospecimen collection (via HRS Health and Retirement Study substudies), and broad data access for approved researchers studying aging and chronic disease.
• UK Biobank: UK Biobank is a large-scale prospective cohort study with deep genetic, lifestyle, and health data on 500,000+ participants, including extensive multi-omics and imaging data. It is comparable to WHI as a population-scale longitudinal research resource with biospecimens and broad data access programs, though broader in scope (general population vs. postmenopausal women).
• Black Women's Health Study: The Black Women's Health Study is a prospective cohort study of 59,000 Black women followed since 1995, focused on identifying causes of health disparities and chronic disease. Comparable to WHI as a long-running women's health longitudinal cohort with biospecimen collection and investigator-driven research on postmenopausal health outcomes and cancer.
• Framingham Heart Study: The Framingham Heart Study is a landmark longitudinal cardiovascular cohort study initiated in 1948, following multiple generations across three cohorts. Like WHI, it is a large-scale government-funded (NHLBI) longitudinal study that has shaped cardiovascular clinical practice, maintains a biospecimen repository, and provides data access to approved investigators through structured application processes.
• Multi-Ethnic Study of Atherosclerosis (MESA): MESA is a long-term NHLBI-funded study of subclinical cardiovascular disease in a multi-ethnic cohort of ~6,800 men and women. It shares WHI's structure as an NIH/NHLBI-funded longitudinal cohort study with biospecimen repository, multi-omics data, and a focus on cardiovascular and chronic disease outcomes in aging populations.
• ARIC Study: The Atherosclerosis Risk in Communities (ARIC) Study is a long-term NHLBI-funded prospective epidemiologic study of cardiovascular disease in ~4,000 men and women from four U.S. communities. Directly comparable to WHI as an NHLBI-funded longitudinal cohort with multi-omics data, biospecimens, and focus on chronic disease outcomes in aging adults.
• Sister Study (NIEHS): The Sister Study is a nationwide prospective study of 50,000+ sisters of women with breast cancer, focused on environmental and genetic risk factors for breast cancer and other diseases. It is directly comparable to WHI as an NIH-funded women's health cohort study with longitudinal follow-up, biospecimen collection, and shared focus on postmenopausal women's health outcomes.

Emerging players

• Cancer Prevention Study-II (CPS-II): CPS-II is a large prospective mortality study of ~1.2 million American men and women enrolled by the American Cancer Society, tracking cancer mortality since 1982. Comparable to WHI as a long-running prospective cohort study focused on cancer and chronic disease outcomes in U.S. adults, though more narrowly focused on mortality than the broader WHI outcomes portfolio.
• All of Us Research Program: All of Us is a newer (launched 2015) NIH-funded longitudinal research program aiming to enroll 1 million+ diverse participants with electronic health records, biospecimens, and survey data. Comparable as a large-scale NIH longitudinal data resource, though broader in demographic focus and newer, with less mature long-term outcomes data than WHI.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/w-h-i

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds4 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Women's Health Initiative